ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma
Cochrane Database of Systematic Reviews
◽
10.1002/14651858.cd013365.pub2
◽
2021
◽
Vol 2021
(9)
◽
Author(s):
Moritz Ernst
◽
Annika Oeser
◽
Burcu Besiroglu
◽
Julia Caro-Valenzuela
◽
Mohamed Abd El Aziz
◽
...
Keyword(s):
Cell Therapy
◽
B Cell
◽
Chimeric Antigen Receptor
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
T Cell Therapy
◽
Large B Cell Lymphoma
◽
Car T Cell Therapy
◽
Car T
◽
Large B Cell
Download Full-text
Related Documents
Cited By
References
Efficacy of Chimeric Antigen Receptor (CAR) T-Cell Therapy, Axicabtagene Ciloleucel (axi-cel), in Patients with Refractory Large B-Cell Lymphoma (LBCL)
Transplantation and Cellular Therapy
◽
10.1016/s2666-6367(21)00519-4
◽
2021
◽
Vol 27
(3)
◽
pp. S403-S404
Author(s):
Sairah Ahmed
◽
Paolo Strati
◽
Luis Fayad
◽
Frederick Hagemeister
◽
Hun Ju Lee
◽
...
Keyword(s):
Cell Therapy
◽
B Cell
◽
Chimeric Antigen Receptor
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
T Cell Therapy
◽
Large B Cell Lymphoma
◽
Car T Cell Therapy
◽
Car T
◽
Large B Cell
Download Full-text
For people with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), what are the effects of CD19-targeted chimeric antigen receptor (CAR) T-cell therapy?
Cochrane Clinical Answers
◽
10.1002/cca.3786
◽
2021
◽
Author(s):
Jane Burch
◽
Sera Tort
Keyword(s):
Cell Therapy
◽
B Cell
◽
Chimeric Antigen Receptor
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
T Cell Therapy
◽
Large B Cell Lymphoma
◽
Car T Cell Therapy
◽
Car T
◽
Large B Cell
Download Full-text
Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma
Cochrane Database of Systematic Reviews
◽
10.1002/14651858.cd013365
◽
2019
◽
Author(s):
Marius Goldkuhle
◽
Moritz Ernst
◽
Lise J Estcourt
◽
Peter Borchmann
◽
Ina Monsef
◽
...
Keyword(s):
Cell Therapy
◽
B Cell
◽
Chimeric Antigen Receptor
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
T Cell Therapy
◽
Large B Cell Lymphoma
◽
Car T Cell Therapy
◽
Car T
◽
Large B Cell
Download Full-text
Incidence and Management of Effusions before and after CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy in Large B-Cell Lymphoma
Transplantation and Cellular Therapy
◽
10.1016/j.jtct.2020.12.025
◽
2020
◽
Author(s):
Abu-Sayeef Mirza
◽
Ambuj Kumar
◽
Hamza Hashmi
◽
Franco Garcia
◽
Constantine N. Logothetis
◽
...
Keyword(s):
Cell Therapy
◽
Chimeric Antigen Receptor
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
T Cell Therapy
◽
Large B Cell Lymphoma
◽
Car T Cell Therapy
◽
Car T
◽
Before And After
◽
Large B Cell
Download Full-text
Fast Facts: CAR T-Cell Therapy in Diffuse Large B-Cell Lymphoma
10.1159/isbn.978-3-318-06935-8
◽
2021
◽
Author(s):
Richard J. Buka
◽
Dee Moloney
Keyword(s):
T Cell
◽
Cell Therapy
◽
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
T Cell Therapy
◽
Large B Cell Lymphoma
◽
Car T Cell Therapy
◽
Car T
◽
Large B Cell
Download Full-text
PCN90 ASSESSMENT OF UTILITIES FOR ADVERSE EVENTS (AES) ASSOCIATED WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY IN LARGE B-CELL LYMPHOMA (LBCL)
Value in Health
◽
10.1016/j.jval.2020.04.1590
◽
2020
◽
Vol 23
◽
pp. S39
Author(s):
T. Howell
◽
L. Matza
◽
M.P. Jun
◽
J. Garcia
◽
A. Powers
◽
...
Keyword(s):
Adverse Events
◽
Cell Therapy
◽
Chimeric Antigen Receptor
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
T Cell Therapy
◽
Large B Cell Lymphoma
◽
Car T Cell Therapy
◽
Car T
◽
Large B Cell
Download Full-text
Rapid relapse of large B‐cell lymphoma after CD19 directed CAR‐T‐cell therapy due to CD‐19 antigen loss
American Journal of Hematology
◽
10.1002/ajh.25591
◽
2019
◽
Vol 94
(10)
◽
Cited By ~ 8
Author(s):
Ali Bukhari
◽
Firas El Chaer
◽
Rima Koka
◽
Zeba Singh
◽
Elizabeth Hutnick
◽
...
Keyword(s):
Cell Therapy
◽
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
T Cell Therapy
◽
Large B Cell Lymphoma
◽
Car T Cell Therapy
◽
Car T
◽
Antigen Loss
◽
Large B Cell
Download Full-text
Retrospective Analysis of ZUMA-1 Data Indicates Better Prognosis for Patients With Large B-Cell Lymphoma Who Relapse > 3 Months Post-CAR T-Cell Therapy
Default Digital Object Group
◽
10.1200/adn.19.190205
◽
2019
◽
Keyword(s):
T Cell
◽
Cell Therapy
◽
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
T Cell Therapy
◽
Large B Cell Lymphoma
◽
Car T Cell Therapy
◽
Car T
◽
Large B Cell
Download Full-text
CAR T-cell therapy in refractory large B-cell lymphoma
The Lancet Oncology
◽
10.1016/s1470-2045(17)30928-2
◽
2018
◽
Vol 19
(1)
◽
pp. e19
◽
Cited By ~ 5
Author(s):
Robert Stirrups
Keyword(s):
T Cell
◽
Cell Therapy
◽
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
T Cell Therapy
◽
Large B Cell Lymphoma
◽
Car T Cell Therapy
◽
Car T
◽
Large B Cell
Download Full-text
CAR T-Cell Therapy for Large B-Cell Lymphoma
Journal of the Advanced Practitioner in Oncology
◽
10.6004/jadpro.2019.10.4.9
◽
2019
◽
Vol 10
(4)
◽
Author(s):
Maritza C. Alencar, DNP, MBA, APRN-BC, BMTCN
Keyword(s):
T Cell
◽
Cell Therapy
◽
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
T Cell Therapy
◽
Large B Cell Lymphoma
◽
Car T Cell Therapy
◽
Car T
◽
Large B Cell
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close
Efficacy of Chimeric Antigen Receptor (CAR) T-Cell Therapy, Axicabtagene Ciloleucel (axi-cel), in Patients with Refractory Large B-Cell Lymphoma (LBCL)